Who is sponsoring NCT07339358?

NCT07339358 is sponsored by World Medica USA, LLC.

What drugs are being tested in NCT07339358?

Interventions in NCT07339358: Flow diverter implantation.

What condition does NCT07339358 study?

NCT07339358 studies Intracranial Aneurysm.

Is NCT07339358 still recruiting?

NCT07339358 is currently not yet recruiting. Last updated 14 January 2026.

Last reviewed 2026-01-14 · How we verify

NCT07339358

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety & Performance of the World Medica World Diverter Embolization Device

Not yet recruiting NA Last updated 14 January 2026

What this trial tests

NA trial testing Flow diverter implantation in Intracranial Aneurysm in 72 participants. Not yet recruiting.

Timeline

31 March 2026

Primary endpoint
31 March 2028

31 August 2028

Quick facts

Lead sponsor	World Medica USA, LLC
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	72
Start date	31 March 2026
Primary completion	31 March 2028
Estimated completion	31 August 2028
Sites	1 location across Spain

Drugs / interventions tested

Flow diverter implantation

Conditions studied

Intracranial Aneurysm — all drugs for Intracranial Aneurysm →

Sponsor

World Medica USA, LLC

Who can join

Adults 22 to 80, any sex, with Intracranial Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to investgiate the safety and clinical performance of the World Diverter Emoblization Device for the endovascular treatment of wide-neck (neck width ≥ 4 mm or dome-to-neck ratio \<2) or fusiform intracranial aneurysms in the internal carotid artery (ICA) from the petrous segment to the terminus arising from a parent vessel with a diameter ≥ 2.5 mm and ≤ 5.5 mm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Intracranial Aneurysm

Currently open trials in the same condition.

NCT07123818 — AI for Detection of Brain Aneurysm: Low-cost Opportunistic Screening · NA · active not recruiting
NCT06494436 — Microvention AnEurysm & STroke Real-life Data cOllection · recruiting
NCT06588543 — Patient-specific Planning of Minimally Invasive Brain Interventions Based on Vascular-hemodynamic Mapping · recruiting
NCT05831202 — SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial · Phase 3 · active not recruiting
NCT06416657 — General Anesthesia vs Local Anesthesia for Endovascular Treatment in Patients With Unruptured Intracranial Aneurysm Usin · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07339358 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by World Medica USA, LLC
Last refreshed: 14 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07339358.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing